SGMO May Be the Most Mispriced Opportunity of 2025-26 Sangamo Therapeutics, Inc.NASDAQ:SGMOaliahmadieng1362 -SGMO is shaping up to be a high-potential trade with both short- and long-term upside. After entering an uptrend in late 2023, the stock is showing strong bullish signals, with technical indicators and moving averages pointing to a favorable buy zone. Fundamentally, it's hitting a key turning point — EPS is moving from negative to positive for the first time, and revenue is projected to grow from \$50M to \$200M by 2028. -Typically, SGMO experiences a major price jump every year, and it’s currently coming out of a low period. A breakout is expected within the coming month. Even under conservative estimates, a 200% return is possible in the near term. But if SGMO revisits its historical highs around $20 — a level it’s touched multiple times in the past — the upside from its current $0.50 range could exceed 4,000%. The financial structure is far stronger than it was during previous lows (like March 2020), making this a classic high-risk, high-reward setup worth watching closely.